• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带植入式静脉输液港的癌症患者计算机断层扫描中纤维蛋白鞘和血栓偶然发现的长期随访及临床相关性

Long-Term Follow-Up and Clinical Relevance of Incidental Findings of Fibrin Sheath and Thrombosis on Computed Tomography Scans of Cancer Patients with Port Catheters.

作者信息

Lichtenstein Thorsten, Mammadov Kamal, Rau Karin, Große Hokamp Nils, Do Thuy D, Maintz David, Chang De-Hua

机构信息

Department of Radiology, University Hospital of Cologne, Cologne, Germany.

Department of Radiology, Klinikum Aschaffenburg, Aschaffenburg, Germany.

出版信息

Ther Clin Risk Manag. 2021 Jan 27;17:111-118. doi: 10.2147/TCRM.S287544. eCollection 2021.

DOI:10.2147/TCRM.S287544
PMID:33536758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7850422/
Abstract

PURPOSE

This retrospective study examined the incidence, progression, and clinical relevance of catheter-related thrombosis (CRT) and/or fibrin sheaths presenting as incidental findings on routine staging computed tomography (CT) scans performed in cancer patients.

PATIENTS AND METHODS

Patients who underwent central venous port catheter (CVC) placement in a tertiary care hospital between September 2010 and August 2013 were followed up for up to five years. Two radiologists assessed the presence of fibrin sheath and thrombosis in consensus in staging CT scan. Patient demographics, type of cancer, preoperative comorbidities, date of CVC placement and CTs, preexisting anticoagulation, as well as the type and treatment of catheter-related complications were determined from the electronic medical record.

RESULTS

A total of 194 patients with 530 CT scans and a mean follow-up time of 394 days were included. Fibrin sheaths and thromboses were seen on 46 scans (8.7%) in 30 patients and 80 scans (15.1%) in 35 patients. The incidence of fibrin sheaths and thromboses was found to be 15.5% and 18%, respectively. The comparison to initial CT reports results indicated that fibrin sheaths or thromboses were missed in 106 examinations (20%). Catheter-associated complications were reported in 14 patients (21.5%) without specific therapy.

CONCLUSION

Fibrin sheaths and CRTs are often overlooked on routine CT scans when patients are asymptomatic. The subsequent high complication rate demonstrates the clinical relevance of the initial incidental finding on CT scan. Further studies should elucidate the effect of thrombolytic agents and interventional radiologic treatment in asymptomatic patients.

摘要

目的

本回顾性研究调查了在癌症患者进行的常规分期计算机断层扫描(CT)中作为偶然发现的导管相关血栓形成(CRT)和/或纤维蛋白鞘的发生率、进展情况及临床相关性。

患者与方法

对2010年9月至2013年8月在一家三级护理医院接受中心静脉端口导管(CVC)置入的患者进行了长达五年的随访。两名放射科医生在分期CT扫描中对纤维蛋白鞘和血栓的存在情况进行了一致性评估。从电子病历中确定患者的人口统计学资料、癌症类型、术前合并症、CVC置入日期和CT检查日期、既往抗凝情况以及导管相关并发症的类型和治疗情况。

结果

共纳入194例患者,进行了530次CT扫描,平均随访时间为394天。30例患者的46次扫描(8.7%)中发现了纤维蛋白鞘和血栓,35例患者的80次扫描(15.1%)中发现了纤维蛋白鞘和血栓。纤维蛋白鞘和血栓的发生率分别为15.5%和18%。与初始CT报告结果的比较表明,在106次检查(20%)中漏诊了纤维蛋白鞘或血栓。14例患者(21.5%)报告了导管相关并发症,但未进行特异性治疗。

结论

当患者无症状时,纤维蛋白鞘和CRT在常规CT扫描中常被忽视。随后较高的并发症发生率证明了CT扫描初始偶然发现的临床相关性。进一步的研究应阐明溶栓药物和介入放射治疗对无症状患者的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/a981d3a6b019/TCRM-17-111-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/40159a35376c/TCRM-17-111-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/4b15cf93d5b7/TCRM-17-111-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/da49fe78a73b/TCRM-17-111-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/a981d3a6b019/TCRM-17-111-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/40159a35376c/TCRM-17-111-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/4b15cf93d5b7/TCRM-17-111-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/da49fe78a73b/TCRM-17-111-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/7850422/a981d3a6b019/TCRM-17-111-g0004.jpg

相似文献

1
Long-Term Follow-Up and Clinical Relevance of Incidental Findings of Fibrin Sheath and Thrombosis on Computed Tomography Scans of Cancer Patients with Port Catheters.携带植入式静脉输液港的癌症患者计算机断层扫描中纤维蛋白鞘和血栓偶然发现的长期随访及临床相关性
Ther Clin Risk Manag. 2021 Jan 27;17:111-118. doi: 10.2147/TCRM.S287544. eCollection 2021.
2
Incidence of ultrasound-detected asymptomatic long-term central vein catheter-related thrombosis and fibrin sheath in cancer patients.癌症患者中超声检测到的无症状长期中心静脉导管相关血栓形成和纤维蛋白鞘的发生率。
Eur J Haematol. 2015 Nov;95(5):472-9. doi: 10.1111/ejh.12519. Epub 2015 May 18.
3
Hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion.血液透析导管相关纤维蛋白鞘:低剂量重组组织型纤溶酶原激活剂输注治疗
J Vasc Interv Radiol. 2000 Oct;11(9):1131-6. doi: 10.1016/s1051-0443(07)61353-0.
4
Presence of retained calcified fibrin sheath after central venous catheter removal: A systematic literature review.中心静脉导管拔除后遗留钙化纤维鞘的存在:系统文献回顾。
J Vasc Access. 2022 Jul;23(4):644-652. doi: 10.1177/1129729820969328. Epub 2020 Nov 4.
5
Retained fibrin sheaths: chest computed tomography findings and clinical associations.纤维蛋白鞘残留:胸部计算机断层扫描结果及临床关联
J Thorac Imaging. 2014 Mar;29(2):118-24. doi: 10.1097/RTI.0b013e318299ff22.
6
Treatment of hemodialysis catheter-associated fibrin sheaths by rt-PA infusion: critical analysis of 124 procedures.通过rt-PA输注治疗血液透析导管相关纤维蛋白鞘:124例手术的批判性分析
J Vasc Interv Radiol. 2001 Jun;12(6):711-5. doi: 10.1016/s1051-0443(07)61441-9.
7
Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis.中心静脉端口导管中的纤维蛋白鞘:门诊低剂量单次注射尿激酶治疗
Ther Clin Risk Manag. 2017 Jan 24;13:111-115. doi: 10.2147/TCRM.S125130. eCollection 2017.
8
Case review and imaging: Treatment of central venous catheter associated fibrin sheath and chronic thrombus with the ClotTriever system.病例回顾与影像学:使用ClotTriever系统治疗中心静脉导管相关纤维蛋白鞘和慢性血栓
Radiol Case Rep. 2023 Nov 24;19(2):553-566. doi: 10.1016/j.radcr.2023.10.062. eCollection 2024 Feb.
9
Central venous access device-related sheaths: a predictor of infective and thrombotic incidence?中心静脉通路装置相关鞘管:感染和血栓形成发生率的预测指标?
Br J Nurs. 2019 Oct 24;28(19):S10-S18. doi: 10.12968/bjon.2019.28.19.S10.
10
Cerebral venous congestion as indication for thrombolytic treatment.脑静脉淤血作为溶栓治疗的指征。
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87. doi: 10.1007/s00270-007-9046-1.

引用本文的文献

1
Ultrasonic characteristics of inserted central catheter related fibroblastic sleeve.置入中心静脉导管相关纤维母细胞套的超声特征
Sci Rep. 2025 Feb 5;15(1):4319. doi: 10.1038/s41598-025-88285-w.
2
Aetiology and management of persistent withdrawal occlusion in venous ports in oncology patients.肿瘤患者静脉港持续性拔出阻塞的病因和处理。
Sci Prog. 2024 Jul-Sep;107(3):368504241260374. doi: 10.1177/00368504241260374.
3
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.

本文引用的文献

1
Incidence, risk factors and medical cost of peripheral intravenous catheter-related complications in hospitalised adult patients.住院成年患者外周静脉导管相关并发症的发生率、危险因素及医疗费用
J Vasc Access. 2022 Jan;23(1):57-66. doi: 10.1177/1129729820978124. Epub 2020 Dec 10.
2
Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports.当前的端口维护策略并不充分:基于植入端口的实际表现的观点。
Medicine (Baltimore). 2019 Nov;98(44):e17757. doi: 10.1097/MD.0000000000017757.
3
Catheter dwell time and risk of catheter failure in adult patients with peripheral venous catheters.
肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
4
Case review and imaging: Treatment of central venous catheter associated fibrin sheath and chronic thrombus with the ClotTriever system.病例回顾与影像学:使用ClotTriever系统治疗中心静脉导管相关纤维蛋白鞘和慢性血栓
Radiol Case Rep. 2023 Nov 24;19(2):553-566. doi: 10.1016/j.radcr.2023.10.062. eCollection 2024 Feb.
5
Assessment of dysfunctional tunneled hemodialysis catheters and outcome of endovascular salvage techniques: a simple solution to a complex problem.功能失调的隧道式血液透析导管评估及血管腔内挽救技术的结果:解决复杂问题的简单方法
Front Cardiovasc Med. 2023 Aug 17;10:1063450. doi: 10.3389/fcvm.2023.1063450. eCollection 2023.
6
Factors affecting mechanical complications of central venous access devices in children.影响儿童中心静脉置管机械并发症的因素。
Pediatr Surg Int. 2022 Jul;38(7):1067-1073. doi: 10.1007/s00383-022-05130-1. Epub 2022 May 5.
成人外周静脉导管留置时间与导管故障风险。
J Clin Nurs. 2019 Dec;28(23-24):4488-4495. doi: 10.1111/jocn.15035. Epub 2019 Sep 15.
4
The natural history of asymptomatic central venous catheter-related thrombosis in critically ill children.危重症患儿无症状中心静脉导管相关性血栓形成的自然病程。
Blood. 2019 Feb 21;133(8):857-866. doi: 10.1182/blood-2018-05-849737. Epub 2018 Oct 30.
5
Anticoagulation for people with cancer and central venous catheters.癌症患者及中心静脉导管置入者的抗凝治疗
Cochrane Database Syst Rev. 2018 Jun 1;6(6):CD006468. doi: 10.1002/14651858.CD006468.pub6.
6
Location and structure of fibrous sheath formed after placing a tunneled hemodialysis catheter in a large pig model.在大型猪模型中置入隧道式血液透析导管后形成的纤维鞘的位置与结构
J Vasc Access. 2018 Sep;19(5):484-491. doi: 10.1177/1129729818760978. Epub 2018 Mar 27.
7
Interventions for treating central venous haemodialysis catheter malfunction.治疗中心静脉血液透析导管故障的干预措施。
Cochrane Database Syst Rev. 2017 Oct 26;10(10):CD011953. doi: 10.1002/14651858.CD011953.pub2.
8
Observational Study of Peripheral Intravenous Catheter Outcomes in Adult Hospitalized Patients: A Multivariable Analysis of Peripheral Intravenous Catheter Failure.成年住院患者外周静脉导管使用结果的观察性研究:外周静脉导管失败的多变量分析
J Hosp Med. 2018 Feb 1;13(2):83-89. doi: 10.12788/jhm.2867. Epub 2017 Oct 18.
9
Epidemiology, diagnosis, prevention and treatment of catheter-related thrombosis in children and adults.儿童和成人相关性血栓的流行病学、诊断、预防和治疗。
Thromb Res. 2017 Sep;157:64-71. doi: 10.1016/j.thromres.2017.07.002. Epub 2017 Jul 4.
10
Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis.中心静脉端口导管中的纤维蛋白鞘:门诊低剂量单次注射尿激酶治疗
Ther Clin Risk Manag. 2017 Jan 24;13:111-115. doi: 10.2147/TCRM.S125130. eCollection 2017.